Square Pharmaceuticals Limited announced earnings results for the third quarter ended March 31, 2021. For the third quarter, the company announced total revenue was BDT 12,770.132 million compared to BDT 12,144.602 million a year ago. Operating income was BDT 4,076.740 million compared to BDT 3,978.772 million a year ago. Net income was BDT 3,862.062 million compared to BDT 3,615.490 million a year ago. Basic earnings per share from continuing operations was BDT 4.36 compared to BDT 4.08 a year ago. For the nine months, total revenue was BDT 37,711.772 million compared to BDT 34,567.388 million a year ago. Operating income was BDT 12,526.700 million compared to BDT 11,398.337 million a year ago. Net income was BDT 11,631.657 million compared to BDT 10,501.300 million a year ago. Basic earnings per share from continuing operations was BDT 13.12 compared to BDT 11.85 a year ago.